Is it time to consider teleophthalmology as a game-changer in the management of diabetic retinopathy?

Currently the “pandemic” of diabetes mellitus is noted. The incidence and prevalence of diabetes and diabetic retinopathy, the most common microvascular complications of diabetes, are exponentially growing due to increased life expectancy in many parts of the world. The increasing number of people suffering from diabetic retinopathy not only highlights medical issues, but also an economic burden, representing a medical and social challenge. It is extremely important to identify a disease as soon as possible and successfully treat it. Technological progress results in developing Artificial Intelligence systems capable of detecting diabetic retinopathy. Current screening will be cost effectively based on the use of advanced digital technologies, in particular teleretinal screening systems.